Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours
- PMID: 27416574
- PMCID: PMC5649963
- DOI: 10.2450/2016.0041-16
Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours
Abstract
Background: Glioblastoma is a highly malignant brain tumour that usually leads to death. Several studies have reported a link between the distribution of ABO blood group antigens and a risk of developing specific types of cancer, although no consensus has been reached. This study aims to investigate the relationship between the distribution of ABO blood group antigens and the incidence of glioblastoma.
Materials and methods: The study cohort consisted of 115 glioblastoma patients who were diagnosed at King Abdullah University Hospital, Jordan, between 2004 and 2015. Three different patient populations made up three control groups and these were selected from among patients at the same institution between 2014 and 2015 as follows: 3,847 healthy blood donors, 654 accidental trauma patients admitted to the Departments of Neurosurgery and Orthopaedics, and 230 age- and sex-matched control subjects recruited blindly from the Departments of Paediatrics and Internal Medicine.
Results: There was a significant association between the distribution of ABO blood group antigens and the incidence of glioblastoma. Post hoc residual analysis revealed that individuals with group A had a higher than expected chance of developing glioblastoma, while individuals with group O had a lower than expected chance. Furthermore, individuals with group A were found to be at a 1.62- to 2.28-fold increased risk of developing glioblastoma compared to individuals with group O.
Discussion: In the present study, we demonstrate that, in Jordan, individuals with group A have an increased risk of developing glioblastoma, while individuals with group O have a reduced risk. These findings suggest that the distribution of ABO blood group antigens is associated with a risk of brain tumours and may play an important role in their development. However, further clinical and experimental investigations are required to confirm this association.
Conflict of interest statement
The Authors declare no conflicts of interest.
Similar articles
-
Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients.Blood Transfus. 2021 Jan;19(1):54-63. doi: 10.2450/2020.0256-20. Epub 2020 Nov 12. Blood Transfus. 2021. PMID: 33196417 Free PMC article.
-
[ABO blood groups in glioblastoma multiforme].Neurol Neurochir Pol. 1979 Mar-Apr;13(2):173-6. Neurol Neurochir Pol. 1979. PMID: 221850 Polish.
-
Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: A population-based cross-sectional study.J Viral Hepat. 2018 Apr;25(4):401-411. doi: 10.1111/jvh.12829. Epub 2018 Jan 12. J Viral Hepat. 2018. PMID: 29193618
-
The secretor status of blood group antigens in the saliva in people with oral cancers: a systematic review.Syst Rev. 2024 Jan 2;13(1):13. doi: 10.1186/s13643-023-02399-8. Syst Rev. 2024. PMID: 38167167 Free PMC article.
-
The prognostic value of ABO blood group in cancer patients.Blood Transfus. 2016 Sep;14(5):434-40. doi: 10.2450/2015.0164-15. Epub 2015 Nov 6. Blood Transfus. 2016. PMID: 26674825 Free PMC article. Review.
Cited by
-
AB Blood Group Confers Higher Risk for Primary Brain Tumors in Pediatrics.Risk Manag Healthc Policy. 2021 Sep 27;14:4031-4035. doi: 10.2147/RMHP.S322546. eCollection 2021. Risk Manag Healthc Policy. 2021. PMID: 34611451 Free PMC article.
-
Blood group O attributes to prolonged progression-free survival, overall survival, and 5-year survival in isocitrate dehydrogenase-wildtype glioblastoma patients with MGMT promoter methylation.Neurooncol Adv. 2025 Feb 20;7(1):vdaf037. doi: 10.1093/noajnl/vdaf037. eCollection 2025 Jan-Dec. Neurooncol Adv. 2025. PMID: 40351837 Free PMC article.
-
Synchronized Glioma Insights: Trends, Blood Group Correlations, Staging Dynamics, and the Vanguard of Liquid Biopsy Advancements.CNS Neurol Disord Drug Targets. 2025;24(1):74-82. doi: 10.2174/0118715273306577240612053957. CNS Neurol Disord Drug Targets. 2025. PMID: 38956913
-
Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.Ther Clin Risk Manag. 2018 May 29;14:991-998. doi: 10.2147/TCRM.S160089. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 29881281 Free PMC article.
-
Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma.Oncotarget. 2017 May 30;8(32):53194-53209. doi: 10.18632/oncotarget.18285. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881804 Free PMC article.
References
-
- Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. - PubMed
-
- Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23:276–92. - PubMed
-
- Zhang BL, He N, Huang YB, et al. ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2014;15:4643–50. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical